TransMedics to Present at Upcoming September Investor Conferences
TransMedics (Nasdaq: TMDX) announced participation in two New York investor conferences in September 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
TransMedics (Nasdaq: TMDX) announced participation in two New York investor conferences in September 2026. Management will join a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 3:20 p.m. EST and at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026, at 9:40 a.m. EST. A live and archived webcast of the fireside chat and the company’s standard investor presentation will be available in the Investors section of the TransMedics website.
Details
News Market Reaction – TMDX
On Sep 1, the first trading day after this news, TMDX closed 3.10% below the previous close. Our momentum scanner recorded 2 alerts for this stock that day. Relative volume reached 2.3x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 1 session.
Key Figures
- Upcoming conferences
- 2 conferences
- September 2026 investor conferences
- Morgan Stanley conference edition
- 24th annual conference
- Global Healthcare Conference
- Morgan Stanley date
- September 14, 2026
- 3:20 p.m. EST fireside chat
- Morgan Stanley time
- 3:20 p.m. EST
- September 14, 2026
- Baird conference date
- September 15, 2026
- 2026 Global Healthcare Conference
- Baird conference time
- 9:40 a.m. EST
- September 15, 2026
Historical Context
-
Revenue increased 21% and guidance low end rose, but net income and operating margin declined.
-
New employee options and restricted stock units created additional equity compensation obligations.
-
Management scheduled participation at the Canaccord Genuity Growth Conference.
-
The company scheduled release of second-quarter financial results for August 4.
-
TransMedics completed its strategic investment in PAD Aviation to support European logistics expansion.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Event: Morgan Stanley 24th Annual Global Healthcare Conference
Date: Monday, September 14, 2026
Time: 3:20 p.m. EST
Event: Baird 2026 Global Healthcare Conference
Date: Tuesday, September 15, 2026
Time: 9:40 a.m. EST
A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian Johnston
Hannah Jeffrey
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-september-investor-conferences-302865120.html
SOURCE TransMedics Group, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.